Teva Pharmaceutical Industries Ltd

Geneos Wealth Management Inc. TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

35,557

Value ($000)

1,110

Weight

0.0%

2016 Q1 - 2025 Q4 (40 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	1,110	0.0%	35,557	12/31/2025
2025 Q3	10/22/2025	728	0.0%	36,057	9/30/2025
2025 Q2	8/18/2025	618	0.0%	36,896	6/30/2025
2025 Q1	5/8/2025	542	0.0%	35,287	3/31/2025
2024 Q4	1/21/2025	510	0.0%	23,122	12/31/2024
2024 Q3	11/14/2024	766	0.0%	42,522	9/30/2024
2024 Q2	7/23/2024	765	0.0%	47,082	6/30/2024
2024 Q1	5/3/2024	663	0.0%	46,982	3/31/2024
2023 Q4	1/26/2024	492	0.0%	47,096	12/31/2023
2023 Q3	10/11/2023	511	0.0%	50,096	9/30/2023
2023 Q2	8/8/2023	386	0.0%	51,282	6/30/2023
2023 Q1	4/25/2023	452	0.0%	51,082	3/31/2023
2022 Q4	1/31/2023	470	0.0%	51,557	12/31/2022
2022 Q3	11/14/2022	441	0.0%	54,657	9/30/2022
2022 Q2	7/22/2022	519	0.0%	65,782	6/30/2022
2022 Q1	5/16/2022	675	0.0%	71,982	3/31/2022
2021 Q4	2/9/2022	488	0.0%	60,938	12/31/2021
2021 Q3	11/9/2021	531	0.0%	54,805	9/30/2021
2021 Q2	7/8/2021	546	0.0%	55,605	6/30/2021
2021 Q1	6/17/2021	652	0.0%	60,986	3/31/2021
2020 Q4	5/19/2021	639	0.0%	61,557	12/31/2020
2020 Q3	9/7/2021	409	0.0%	46,907	9/30/2020
2020 Q2	9/7/2021	677	0.0%	55,572	6/30/2020
2020 Q1	9/7/2021	347	0.0%	46,022	3/31/2020
2019 Q4	9/7/2021	369	0.0%	37,094	12/31/2019
2019 Q3	9/7/2021	239	0.0%	34,544	9/30/2019
2019 Q2	9/7/2021	321	0.0%	34,851	6/30/2019
2019 Q1	9/7/2021	525	0.0%	33,531	3/31/2019
2018 Q4	9/7/2021	515	0.0%	32,826	12/31/2018
2018 Q3	9/7/2021	749	0.0%	34,776	9/30/2018
2018 Q2	9/7/2021	289	0.0%	11,894	6/30/2018
2018 Q1	9/7/2021	373	0.0%	21,851	3/31/2018
2017 Q4	9/7/2021	740	0.1%	39,083	12/31/2017
2017 Q3	9/7/2021	706	0.1%	40,158	9/30/2017
2017 Q2	9/7/2021	1,370	0.1%	41,255	6/30/2017
2017 Q1	9/7/2021	942	0.1%	29,370	3/31/2017
2016 Q4	9/7/2021	940	0.1%	25,936	12/31/2016
2016 Q3	9/7/2021	315	0.0%	6,851	9/30/2016
2016 Q2	9/7/2021	326	0.0%	6,518	6/30/2016
2016 Q1	9/7/2021	370	0.1%	6,835	3/31/2016